International Journal of Biomedicine (Dec 2021)

Dyslipidemia as Predictor of Missed Miscarriage

  • Agamurad A. Orazmuradov,
  • Sergey G. Morozov ,
  • Anastasiya N. Akhmatova,
  • Khalid Haddad,
  • Alexander M. Lopatin,
  • Fatima U. Ramazanova1,
  • Irina V. Bekbaeva,
  • Sergey I. Kyrtikov,
  • Zhasmina Z. Suleymanova,
  • Aleksey A. Lukaev

DOI
https://doi.org/10.21103/Article11(4)_OA4
Journal volume & issue
Vol. 11, no. 4
pp. 418 – 421

Abstract

Read online

Background: This study aimed at finding the diagnostic and prognostic possibilities of determining apoC-II, as a serological marker for MM in early gestation. Methods and Results: The study included 182 pregnant women aged between 18 and 45 years at gestational age under 11 weeks. All women were divided into 3 groups. Group 1 (Gr1) included 90 women with MM; Group 2 (Gr2) included 52 women with spontaneous miscarriage; Group 3 included 40 women without pathology (control group [CG]). Lipid metabolism disorders were diagnosed according to the Russian national recommendations of the VII revision(the Russian Society of Cardiologists [RSC, 2020]), considering the European recommendations (2019). Proteomic analysis of the blood serum was performed using LC-MS. Abnormalities in the lipid profile were more common in patients with MM and spontaneous abortions: 62.2% and 59.7% of cases, respectively, which correlates with the identified marker apoC-II in Gr1 and Gr2. Conclusion: ApoC-II can be considered as the most promising serologic marker for MM in the early gestation period for women with dyslipidemia.

Keywords